M

Magellan Health Inc
F:MAH1

Watchlist Manager
Magellan Health Inc
F:MAH1
Watchlist
Price: 83.5 EUR
Market Cap: €2.2B

EV/EBITDA

12.9
Current
1%
More Expensive
vs 3-y average of 12.8

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
12.9
=
Enterprise Value
€1.9B
/
EBITDA
$147.8m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
12.9
=
Enterprise Value
€1.9B
/
EBITDA
$147.8m

Valuation Scenarios

Magellan Health Inc is trading above its 3-year average

If EV/EBITDA returns to its 3-Year Average (12.8), the stock would be worth €82.62 (1% downside from current price).

Statistics
Positive Scenarios
1/4
Maximum Downside
-1%
Maximum Upside
+11%
Average Upside
2%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 12.9 €83.5
0%
3-Year Average 12.8 €82.62
-1%
5-Year Average 12.9 €83.33
0%
Industry Average 12.9 €83.37
0%
Country Average 14.4 €92.88
+11%

Forward EV/EBITDA
Today’s price vs future ebitda

Not enough data available to calculate forward EV/EBITDA

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
US
Magellan Health Inc
F:MAH1
2.2B EUR 12.9 8.5
US
UnitedHealth Group Inc
NYSE:UNH
313.4B USD 0 26
US
Anthem Inc
LSE:0HG8
84.7B USD 0 15.3
US
Elevance Health Inc
NYSE:ELV
72.4B USD 0 12.8
US
Humana Inc
NYSE:HUM
26.2B USD 0 22.1
US
Centene Corp
NYSE:CNC
19.2B USD 0 -2.9
US
Molina Healthcare Inc
NYSE:MOH
7.7B USD 3.6 16.3
US
Healthequity Inc
NASDAQ:HQY
7.2B USD 16 33.3
BR
Odontoprev SA
BOVESPA:ODPV3
8.5B BRL 9.9 14.6
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 11.4 25.2
US
Clover Health Investments Corp
NASDAQ:CLOV
1.2B USD -13.4 -14.5
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
M
Magellan Health Inc
F:MAH1
Average EV/EBITDA: 10.8
12.9
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
Not Available N/A N/A
US
A
Anthem Inc
LSE:0HG8
Not Available N/A N/A
US
Elevance Health Inc
NYSE:ELV
Not Available N/A N/A
US
Humana Inc
NYSE:HUM
Not Available N/A N/A
US
Centene Corp
NYSE:CNC
Not Available N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
3.6
7%
0.5
US
Healthequity Inc
NASDAQ:HQY
16
17%
0.9
BR
Odontoprev SA
BOVESPA:ODPV3
9.9
4%
2.5
US
Progyny Inc
NASDAQ:PGNY
11.4
45%
0.3
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -13.4 N/A N/A
P/E Multiple
Earnings Growth PEG
US
M
Magellan Health Inc
F:MAH1
Average P/E: 19.3
8.5
N/A N/A
US
UnitedHealth Group Inc
NYSE:UNH
26
22%
1.2
US
A
Anthem Inc
LSE:0HG8
15.3
10%
1.5
US
Elevance Health Inc
NYSE:ELV
12.8
10%
1.3
US
Humana Inc
NYSE:HUM
22.1
38%
0.6
US
Centene Corp
NYSE:CNC
Negative Multiple: -2.9 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
16.3
14%
1.2
US
Healthequity Inc
NASDAQ:HQY
33.3
35%
1
BR
Odontoprev SA
BOVESPA:ODPV3
14.6
4%
3.6
US
Progyny Inc
NASDAQ:PGNY
25.2
35%
0.7
US
Clover Health Investments Corp
NASDAQ:CLOV
Negative Multiple: -14.5 N/A N/A

Market Distribution

In line with most companies in the United States of America
Percentile
45th
Based on 9 875 companies
45th percentile
12.9
Low
0 — 10
Typical Range
10 — 21.5
High
21.5 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 10
Median 14.4
70th Percentile 21.5
Max 1 767 274.1

Magellan Health Inc
Glance View

Market Cap
2.2B EUR
Industry
Health Care

In the world of healthcare innovation, Magellan Health Inc. has carved a notable niche, presenting a fresh compass in navigating complex healthcare systems. Founded with a keen focus on specialized management in the healthcare industry, Magellan Health has grown into a formidable player by providing comprehensive solutions in behavioral health, specialty healthcare, and pharmacy management. The company's journey is centered around bridging gaps within the healthcare system, offering services that address mental health and substance abuse issues, emphasizing its commitment to fostering holistic well-being. By managing these critical areas, Magellan partners with payers, providers, and public sector agencies, effectively orchestrating a network that alleviates the burden of mental health challenges and optimizes patient outcomes across the board. At its core, Magellan's financial engine hums through its innovative integration of managed care programs and technology-driven solutions. It generates revenue by offering tailored solutions that help reduce costs while improving access and outcomes. Through a mix of managed care plans for specialty populations and cutting-edge digital platforms, Magellan enhances the delivery of healthcare services, ensuring they reach those who need them most. The company's business model thrives on performance-based contracts and management fees, where success is measured by its ability to improve health care quality and efficiency. By continuously investing in technology and analytics, Magellan Health not only advances its core mission but also sustains a robust economic model that remains resilient amid evolving health sector dynamics.

MAH1 Intrinsic Value
Not Available
M
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett